Product analysis
Melatonin Lozenge 2.5 mg may help you fall asleep sooner by supporting the body's sleep-timing signal, with a favorable cost per serving.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
The specific ingredient preparations are unspecified, so their quality cannot be confidently compared. The lozenge description alone does not establish a distinct absorption or release advantage.
Ingredient Transparency31
The melatonin amount is stated, but the carbohydrate amount is missing. Specific preparation details are also unspecified, limiting comparisons beyond the named serving.
Value For Money88
The melatonin serving is favorably priced. Value for the carbohydrate contribution is uncertain, though melatonin provides the main basis for the favorable cost comparison.
Customer Satisfaction81
Customer ratings are very positive across a substantial set of reviews. They describe satisfaction without establishing a sleep effect for every user.
Product Focus92
The formula has a clear role in supporting sleep timing and helping shorten the time to fall asleep. Its amount is within lower ranges used for adult sleep onset, without establishing sustained-release effects or a solution for chronic insomnia.
- Format
Lozenge - Container
- 100 Liquid(s)
- Per serving
- $0.06
- Customer rating
- 4.7 · 1,079 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Total Carbohydrates | 0 Gram(s) | |
Melatonin | 2.5 mg |
How this ingredient is rated
Active Ingredient Quality & Bioavailability0
Third-Party Purity Verification
Dose, Safety & Label Transparency100
Physiological Dosing Alignment
Value100
Price Per Serving Efficiency
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Meta-analysis: melatonin for the treatment of primary sleep disorders.
- Melatonin treatment for age-related insomnia.
- The Effectiveness of Melatonin for Sleep Disturbances in Parkinson' Disease: Systematic Review and Meta-Analysis.
- Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
- Effects of exogenous melatonin on sleep: a meta-analysis.